Life Sciences
Global Autoimmune Disease Diagnostics Market (By Disease, Test Types, Region), Key Company Profiles, Strategy, Financial Insights, Recent Developments - Forecast To 2030
The global autoimmune disease diagnostics market is predicted to reach US$ 10.5 Billion by 2030. In June 2023, AstraZeneca signed an agreement with Quell Therapeutics potentially worth more than US$ 2 billion to develop cell therapies that could cure autoimmune diseases. As per the American Autoimmune Related Diseases Association, around 50 million Americans currently suffer from autoimmune related disorders.
Global Wound Care Market (by Product Type, Application, Wound Type, Region And Company), Size, Share, Acquisitions, Recent Developments - Forecast To 2030
The global wound care market is predicted to surpass US$ 30.1 Billion by 2030. Over the years, wound care product categories have continued to expand with the continuous arrival of new and advanced products. The developments in wound dressings have led to a shift from simple dressings to advanced products and devices that incorporate pharmaceutically active ingredients.
Saudi Arabia In-Vitro Diagnostics (IVD) Market (By Technology, Application, Product, End User), Size, Share, Major Deals, Key Players Analysis, Recent Developments - Forecast To 2028
Saudi Arabia In-Vitro Diagnostics (IVD) market is predicted to reach US$ 1,176 Million by 2028. Saudi Arabian government is taking number of initiatives to improve the healthcare sector in the country. Under Vision 2030, the Saudi Arabian Government plans to invest over US$ 65 Billion to develop the country’s healthcare infrastructure. The government has set the target of privatizing 290 hospitals and 2,300 primary health centers by 2030.
Japan In-Vitro Diagnostics (IVD) Market (By Segment And Company), Size, Share, Major Deals, Trends And Recent Developments - Forecast To 2028
Japan In Vitro Diagnostics (IVD) market is predicted to surpass US$ 5.5 Billion by 2028. The population of Japan is aging rapidly. For instance, as of November 2022, close to 36.5 million people in Japan were estimated to be within the age group 65 and over. Thus, Japan’s quickly aging population leads to an explosion of chronic conditions such as heart disease and cancer.  All of these conditions can be diagnosed and monitored using IVD products.
 Market (By Segment & Company), Size, Share, Major Deals, Recent Developments - Forecast to 2028.JPG)
China In-Vitro Diagnostics (IVD) Market (By Segment And Company), Size, Share, Regulations, Reimbursement, Major Deals, Trends & Recent Developments - Forecast To 2028
China In-Vitro Diagnostics (IVD) market is predicted to exceed US$ 25 Billion by 2028. Immunoassays accounted for lion’s share of the total China IVD market, and is likely to maintain its dominant position over the forecast period as well. Molecular Testing is the fastest growing segment of the China IVD market, driven by increasing demand for polymerase chain reaction (PCR) products in China.
 Market and Forecast to 2028.JPG)
South Korea In-Vitro Diagnostics (IVD) Market (By Technology, Application, Product, End User), Size, Share, Major Deals, Key Players Analysis, Government Initiatives, Recent Developments - Forecast To 2028
South Korea In-Vitro Diagnostics (IVD) market is predicted to reach US$ 3.7 Billion by 2028. The Korean ‘Act on In Vitro Diagnostic Medical Devices’ came into effect on May 1, 2020, presenting an independent legal foundation to reinforce the IVD industry by promoting advanced technology to be applied promptly. Further, owing to the vast opportunities in this region, key players are coming up with market development strategies to leverage it.Â
Global Home Infusion Therapy Market (By Product, Application, Region), Impact Of COVID-19, Key Company Profiles, Trends And Recent Developments - Forecast To 2028
In 2021, Infusion pumps dominated the market with over 50% share of the total market. This can be attributed to their increasing use and efficiency in delivering nutrition, medications, and other required fluids into a patient’s body in a controlled manner. Nowadays, smart pumps are widely used as these pumps contain advanced features such as barcode technology, which helps in the verification of a patient’s identity and prevents drug administration errors.
Global Radiology Information System Market (By Type, Deployment, Component, End Users, Region), Impact Of COVID-19, Key Company Profiles, Recent Developments - Forecast To 2028
The global market for radiology information systems (RIS) is expected to increase rapidly as a result of rising number of radiology professionals and practices, growing preference for web-based solutions, technological development and rising healthcare IT spending, which presents favorable possibilities for market growth.
Global Point Of Care Testing (POCT) Market (By Diagnostics Segment, Mode, Platform, End Users, Region), Impact Of COVID-19, Recent Developments, Company Profiles - Forecast To 2028
The global point of care testing (POCT) market is predicted to reach nearly US$ 65 Billion by 2028. Point-of-care (POC) testing has skyrocketed in the last 20 years as demand for accurate and fast testing has blossomed both inside and outside the hospital setting. Based on diagnostics segment, the point of care testing market is dominated by blood glucose testing segment.
Global Retinal Surgery Devices Market (By Device Segment, Application, Regional Analysis), Impact Of COVID-19, Company Profiles, Major Deals, Strategy And Recent Developments – Forecast To 2027
The global retinal surgery devices market is predicted to reach US$ 3.7 Billion by 2027. Diabetic retinopathy is the most common diabetic eye disease and a leading cause of blindness in American adults. Among the device types, vitrectomy packs segment accounts for the largest revenue share in the global retinal surgery devices market.
Global Food Safety Testing Market (by Contaminants, Pathogens, Type Of Food Tested, Technology/Method, Region), Impact Of COVID-19, Company Profiles, Major Acquisitions And Recent Developments - Forecast To 2028
The global food safety testing market is predicted to surpass US$ 32 Billion by 2028. Food-related queries and complaints are continuously rising, which reflects a growing concern of government authorities and consumers. Companies engaged in the manufacturing and distributions of food products are mandated by respective regional and international regulatory agencies to implement food safety testing and certification.
Microfluidic Devices Market (by Device Type, Material, Application, Industry, Geography), Impact Of COVID-19, Company Profiles And Recent Developments - Global Forecast To 2028
The global microfluidic devices market is predicted to reach US$ 34.5 Billion by 2028. Microfluidics is the technology that deals with the flow of liquids through microscopic channels such as chips, nozzles, and pumps. Microfluidics is à huge potential ar
Liquid Biopsy Market (by Circulating Biomarker, Product, Application, End Users, Clinical Application, Cancer Types, Sample Type, Regional & Country Wise Analysis), Impact Of COVID-19, Initiatives, Funding, Major Deals, Company Profiles And Recent Develop
The global liquid biopsy market is predicted to surpass US$ 11 Billion by 2030. In March 2022, the Japanese Ministry of Health, Labour and Welfare granted regulatory approval of Guardant360 CDx, a liquid biopsy test for tumor mutation profiling, also know
Autoimmune Disease Diagnostics Market (By Disease, Test Types, Region), Impact Of COVID-19, Key Company Profiles, Recent Developments - Global Forecast To 2028
The global autoimmune disease diagnostics market was valued around US$ 14 Billion in 2021. Manufacturers in the autoimmune disease diagnostics market are focusing on developing novel technologies for maximum testing within a minimum period. On the basis
Japan In-Vitro Diagnostics (IVD) Market, Impact Of COVID-19, Size, Share, Major Deals, Company Analysis, Trends And Recent Developments - Forecast To 2028
Japan In Vitro Diagnostics (IVD) market is predicted to reach nearly US$ 4.5 Billion by 2028. In 2020, the COVID-19 pandemic has restricted the growth of Japan IVD market, as routine procedures were delayed by social restrictions and other precautionary m